Recent Events & Catalysts
Regeneron Pharmaceuticals (REGN) — real, dated facts. Not a claim about what caused any single day's price move.
News
Longleaf Partners Global Fund Q2 2026 Portfolio Review
SeekingAlpha · today
1 Large-Cap Stock with Exciting Potential and 2 We Turn Down
Yahoo · 1d ago
Own Regeneron For Biotech Growth? Incyte Is Making Its Case.
Yahoo · 2d ago
Baird International And Global Growth Funds Q2 2026 Contributors And Detractors
SeekingAlpha · 2d ago
Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2
Yahoo · 2d ago
Piper Sandler Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $854
Benzinga · 6d ago
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry
SeekingAlpha · 6d ago
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
Yahoo · 7d ago
SEC Filings (90 days)
Results of operations (earnings release)
Filed 2026-07-06 · 9d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-17 · 28d ago
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-04-29 · 77d ago · Material
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.